Navigation Links
Paul Chew Appointed to sanofi-aventis U.S. Chief Science Officer/Chief Medical Officer
Date:3/16/2009

BRIDGEWATER, N.J., March 16 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. announced today that Paul Chew, M.D., has been appointed to Chief Science Officer/Chief Medical Officer, U.S., effective April 1. He was previously President, R&D, sanofi-aventis, U.S.

As the company's Chief Science Officer and Chief Medical Officer, Paul Chew will establish a unified medical voice for sanofi-aventis U.S. among internal and external stakeholders. He will be responsible for overseeing U.S. Medical Affairs in addition to his continued oversight of the U.S. R&D organization in coordination with the Group in Paris. Further, Paul Chew will be charged with representing accurate and timely clinical and safety information to health authorities, payers, patients and physicians that will foster safe and appropriate use of our products.

Paul Chew's primary reporting will be to Greg Irace, President and Chief Executive Officer, sanofi-aventis U.S., in addition to Marc Cluzel, Group Senior Vice President of R&D and Jean-Pierre Lehner, Group Chief Medical Officer.

"Paul brings deep, scientific expertise and proven leadership to both the R&D and Medical functions in the U.S. - a critical area in which the science and the business of our industry intersect," said Greg Irace. "In this new role, Paul will be in a position to bring greater scientific and product insights to our organization, greater clarity and dialogue with members of the healthcare system and, ultimately, greater value to patients in the form of improved health outcomes."

The new role of Chief Science Officer/Chief Medical Officer is part of the company's overall organizational drive to ensure all components of the U.S. affiliate work in a coordinated manner to achieve harmonized processes, cost-effectiveness and best practice sharing in the design, conduct and monitoring of clinical studies.

About sanofi-aventis

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

For more information, www.sanofi-aventis.us or www.sanofi-aventis.com

    Media Contact:

    Lisa Buffington
    908-981-6569
    Lisa.Buffington@sanofi-aventis.com


'/>"/>
SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. Jim Yong Kim Appointed 17th President of Dartmouth College
2. Industry Veterans Appointed to Key Leadership Posts at Healthcare Informatics Associates (HIA), an InfoLogix Company
3. Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
4. Brickson Diamond Appointed Board Chair of National Hospice Foundation
5. Valensa Internationals Dr. Rudi E. Moerck Appointed CEO
6. Margaret Laub Appointed to IntelliDOT Board of Directors
7. Laurence Debroux Appointed Chief Strategic Officer (CSO)
8. Jean-Pierre Lehner Appointed Chief Medical Officer
9. Alice Stollenwerk Petrulis, MD, FACP, Appointed to NQF Care Coordination Committee
10. Former Assistant Secretary for Aging, The Honorable Josefina G. Carbonell, Appointed Senior Vice President at Independent Living Systems
11. Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... , ... MelaKids, a Laredo-based company, has introduced a new concept for children’s ... gives us a full supply of melanin – in the back of the eye ... pigment; however, around the age of thirty, we develop a yellow-brown pigment in the ...
(Date:9/19/2017)... , ... September 19, 2017 , ... The Workgroup ... of health IT to create efficiencies in healthcare information exchange and a trusted advisor ... of their latest industry white paper, entitled Barriers to Adoption of the ERA ...
(Date:9/19/2017)... ... ... Public outrage over the toxins that exist in tap water and the lack ... itself to research, develop and ultimately supply consumers with healthy drinking water alternatives. Vitev ... alkaline water technologies, water filtration systems, and consumer education. , ...
(Date:9/19/2017)... ... September 19, 2017 , ... Bone Solutions Inc. (BSI), an ... orthopedic medical device, OsteoCrete®. OsteoCrete® bone void filler is designed to assist with ... magnesium, a critical property for bone health and development. , “We’re excited to ...
(Date:9/19/2017)... ... September 19, 2017 , ... Ron Norman, CEO of Team Decades, ... of making a distinct rather than generic impression in the job market if one ... a stack of resumes knows that the first impression they give off is not ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... Sept. 6, 2017   PDI , a leader in ... host an educational session focused on the role of ... prevention at the 2017 Annual Scientific Meeting of the ... place at the Phoenix Convention ... Sept. 16-19, will also feature PDI,s Prevantics® Device ...
(Date:9/6/2017)... 2017 Eli Lilly and Company (NYSE: ... data for galcanezumab and lasmiditan, two investigational treatments for ... Society (IHC) taking place Sept. 7-10 in ... new, long-term data from an open-label study evaluating the ... mg and 240 mg) for the prevention of migraine. ...
(Date:9/5/2017)... NEWTOWN, Pa. , Sept. 5, 2017  Xyntek Inc. has announced another ... opened a new Midwest office to meet the growing demands of customer engagements ... Xyntek's new Midwest office is located at ... ... demands of customer engagements regionally. ...
Breaking Medicine Technology: